Resources‎ > ‎Publications‎ > ‎


Collaborating Author Molecular Biology Research Papers - international

  1. Urashima M, Ogata A, Chauhan D, Vidriales MB, Teoh G, Hoshi Y, Schlossman RL, DeCaprio JA, Anderson KC. Interleukin-6 promotes multiple myeloma cell growth via phosphorylation of retinoblastoma protein. Blood 1996 Sep 15;88(6):2219-2227.

  2. Urashima M, Hoshi Y, Sugimoto Y, Kaihara C, Matsuzaki M, Chauhan D, Ogata A, Teoh G, DeCaprio JA, Anderson KC. A novel pre-B acute lymphoblastic leukemia cell line with chromosomal translocation between p16(INK4A)/p15(INK4B) tumor suppressor and immunoglobulin heavy chain genes: TGFbeta/IL-7 inhibitory signaling mechanism. Leukemia 1996 Oct;10(10):1576-1583.

  3. Chauhan D, Kharbanda S, Ogata A, Urashima M, Teoh G, Robertson M, Kufe DW, Anderson KC. Interleukin-6 inhibits Fas-induced apoptosis and stress-activated protein kinase activation in multiple myeloma cells. Blood 1997 Jan 1;89(1):227-234.

  4. Urashima M, Teoh G, Chauhan D, Hoshi Y, Ogata A, Treon SP, Schlossman RL, Anderson KC. Interleukin-6 overcomes p21WAF1 upregulation and G1 growth arrest induced by dexamethasone and interferon-gamma in multiple myeloma cells. Blood 1997 Jul 1;90(1):279-289.

  5. Urashima M, Chen BP, Chen S, Pinkus GS, Bronson RT, Dedera DA, Hoshi Y, Teoh G, Ogata A, Treon SP, Chauhan D, Anderson KC. The development of a model for the homing of multiple myeloma cells to human bone marrow. Blood 1997 Jul 15;90(2):754-765.

  6. Chauhan D, Pandey P, Ogata A, Teoh G, Treon S, Urashima M, Kharbanda S, Anderson KC. Dexamethasone induces apoptosis of multiple myeloma cells in a JNK/SAP kinase independent mechanism. Oncogene 1997 Aug 14;15(7):837-843.

  7. Ogata A, Chauhan D, Teoh G, Treon SP, Urashima M, Schlossman RL, Anderson KC. IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade. J Immunol 1997 Sep 1;159(5):2212-2221.

  8. Urashima M, DeCaprio JA, Chauhan D, Teoh G, Ogata A, Treon SP, Hoshi Y, Anderson KC. p16INK4A promotes differentiation and inhibits apoptosis of JKB acute lymphoblastic leukemia cells. Blood 1997 Nov 15;90(10):4106-4115.

  9. Urashima M, Teoh G, Ogata A, Chauhan D, Treon SP, Hoshi Y, DeCaprio JA, Anderson KC. Role of CDK4 and p16INK4A in interleukin-6-mediated growth of multiple myeloma. Leukemia 1997 Nov;11(11):1957-1963.

  10. Chauhan D, Pandey P, Ogata A, Teoh G, Krett N, Halgren R, Rosen S, Kufe D, Kharbanda S, Anderson K. Cytochrome c-dependent and -independent induction of apoptosis in multiple myeloma cells. J Biol Chem 1997 Nov 28;272(48):29995-29997.

  11. Urashima M, Teoh G, Ogata A, Chauhan D, Treon SP, Sugimoto Y, Kaihara C, Matsuzaki M, Hoshi Y, DeCaprio JA, Anderson KC. Characterization of p16(INK4A) expression in multiple myeloma and plasma cell leukemia. Clin Cancer Res 1997 Nov;3(11):2173-2179.

  12. Ogata A, Chauhan D, Urashima M, Teoh G, Treon SP, Anderson KC. Blockade of mitogen-activated protein kinase cascade signaling in interleukin 6-independent multiple myeloma cells. Clin Cancer Res 1997 Jun;3(6):1017-1022.

  13. Urashima M, Teoh G, Chauhan D, Ogata A, Shirahama S, Kaihara C, Matsuzaki M, Matsushima H, Akiyama M, Yuza Y, Maekawa K, Anderson KC. MDM2 protein overexpression inhibits apoptosis of TF-1 granulocyte-macrophage colony-stimulating factor-dependent acute myeloblastic leukemia cells. Blood 1998 Aug 1;92(3):959-967.

  14. Treon SP, Teoh G, Urashima M, Ogata A, Chauhan D, Webb IJ, Anderson KC. Anti-estrogens induce apoptosis of multiple myeloma cells. Blood 1998 Sep 1;92(5):1749-1757.

  15. Treon SP, Mollick JA, Urashima M, Teoh G, Chauhan D, Ogata A, Raje N, Hilgers JHM, Nadler L, Belch AR, Pilarski LM, Anderson KC. Muc-1 core protein is expressed on multiple myeloma cells and is induced by dexamethasone. Blood 1999 Feb 15;93(4):1287-1298.

  16. Chauhan D, Bharti A, Raje N, Gustafson E, Pinkus GS, Pinkus JL, Teoh G, Hideshima T, Treon SP, Fingeroth JD, Anderson KC. Detection of Kaposi's sarcoma herpesvirus DNA sequences in multiple myeloma bone marrow stromal cells. Blood 1999 Mar 1;93(5):1482-1486.

  17. Raje N, Gong J, Chauhan D, Teoh G, Avigan D, Wu Z, Chen D, Treon SP, Webb IJ, Kufe DW, Anderson KC. Bone marrow and peripheral blood dendritic cells from patients with multiple myeloma are phenotypically and functionally normal despite the detection of Kaposi's sarcoma herpesvirus gene sequences. Blood 1999 Mar 1;93(5):1487-1495.

  18. Chauhan D, Hideshima T, Treon S, Teoh G, Raje N, Shima Y, Tai YT, Li W, Fan J, DeCaprio J, Anderson KC. Functional interaction between retinoblastoma protein and stress-activated protein kinase in multiple myeloma cells. Cancer Res 1999 Mar 15;59(6):1192-1195.

  19. Urashima M, Teoh G, Akiyama M, Yuza Y, Anderson KC, Maekawa K. Restoration of p16INK4A protein induces myogenic differentiation in RD rhabdomyosarcoma cells. Br J Cancer 1999 Mar;79(7-8):1032-1036.

  20. Chauhan D, Hideshima T, Pandey P, Treon S, Teoh G, Raje N, Rosen S, Krett N, Husson H, Avraham S, Kharbanda S, Anderson KC. RAFTK/PYK2-dependent and –independent apoptosis in multiple myeloma cells. Oncogene 1999 Nov 18;18(48):6733-6740.

  21. Tai Y, Teoh G, Shima Y, Chauhan D, Treon SP, Raje N, Hideshima T, Davies FE, Anderson KC. Isolation and characterization of human multiple myeloma cell enriched populations. J Immunol Methods 2000 Feb 21;235(1-2):11-19.

  22. Hideshima T, Chauhan D, Teoh G, Raje N, Treon SP, Tai Yu-Tzu, Shima Y, Anderson KC. Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi’s sarcoma-associated herpes virus-encoded viral interleukin 6. Clin Cancer Res 2000 Mar 6(3):1180-1189.

  23. Raje N, Kica G, Chauhan D, Zhang Y, Teoh G, Treon SP, Hideshima T, Deng JH, Gao SJ, Alsina M, Wally J, Davies FE, Tai YT, Pinkus GS, Pinkus JL, Skinner M, Comenzo RL, Anderson KC. Kaposi's sarcoma-associated herpesvirus gene sequences are detectable at low copy number in primary amyloidosis. Amyloid. 2000 Jun;7(2):126-132.

  24. Tai Y-T, Teoh G, Lin B, Davies FE, Chauhan D, Treon SP, Raje N, Hideshima T, Shima Y, Podar K, Anderson KC. Ku86 variant expression and function in multiple myeloma cells is associated with increased sensitivity to DNA damage. J Immunol 2000 Nov 165:6347-6355.

Collaborating Author Molecular Biology Research Papers - local

  1. Liew PX, Gullo  C, Teoh GKH, Hwang WKH. Use of Phage Display to Isolate Specific Human Monoclonal Antibody Fragments against a Potential Target for Multiple Myeloma. Ann Acad Med Singapore. 2009 Jul;38(7):621-9.

Collaborating Author Clinical Research Papers - international

  1. Linn YC, Tien SL, Lim LC, Lee LH, Teoh G, Goh YT, Tan P. Haemophagocytosis in bone marrow aspirate--a review of the clinical course of 10 cases. Acta Haematol 1995;94(4):182-191.

  2. Hwang W, Dearden C, Loh YSM, Linn YC, Tien SL, Teoh GKH, How GF, Heng KK, Goh TY, Lee LH. Outpatient-Based Therapy of Oral Fludarabine and Subcutaneous Alemtuzumab for Asian Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia. Adv Hematol. 2009;2009:547582. Epub 2008 Feb 25.

  3. Tan Daryl, Teoh Gerrard, Lau LC, Lim Alvin, Lim T, Yap Kok, Lao ZT, Wee Nelson, Choo Christine, Wee H, Su Su, Lee Y, Lee Lai, Hwang William, Goh Y. An Abnormal Non-Hyperdiploid Karyotype is a Significant Adverse Prognostic Factor for Multiple Myeloma in the Bortezomib Era. Am J Hematol. 2010 Oct;85(10):752-6.

  4. Tan D, Kim K, Kim JS, Eom HS, Teoh G, Ong KH, Goh YT, Durie BG, Chng WJ, Lee JH. The impact of upfront versus sequential use of bortezomib among patients with newly diagnosed multiple myeloma (MM): A joint analysis of the Singapore MM Study Group and the Korean MM Working Party for the Asian myeloma network. Leuk Res. 2013 Jun 28. 

Collaborating Author Clinical Papers - local
  1. Koh LP, Goh YT, Teoh G, Tan P. Treatment of acute promyelocytic leukaemia using a combination of all-trans-retinoic-acid and chemotherapy. Ann Acad Med, Singapore 2001 30:401-408.

  2. Koh LP, Linn YC, Teoh G, Goh YT,Tan P. Autologous transplantation for multiple myeloma. Ann Acad Med, Singapore 2002 31(6):731-737.